<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rivera-Correa J</submitter><funding>NIDDK NIH HHS</funding><funding>National Institute of Health</funding><funding>NCI NIH HHS</funding><funding>NIAMS NIH HHS</funding><funding>NIH HHS</funding><pagination>e180507</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11949073</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(5)</volume><pubmed_abstract>The mechanisms utilized by differentiating B cells to withstand highly damaging conditions generated during severe infections, like the massive hemolysis that accompanies malaria, are poorly understood. Here, we demonstrate that ROCK1 regulates B cell differentiation in hostile environments replete with pathogen-associated molecular patterns (PAMPs) and high levels of heme by controlling 2 key heme-regulated molecules, BACH2 and heme-regulated eIF2α kinase (HRI). ROCK1 phosphorylates BACH2 and protects it from heme-driven degradation. As B cells differentiate, furthermore, ROCK1 restrains their pro-inflammatory potential and helps them handle the heightened stress imparted by the presence of PAMPs and heme by controlling HRI, a key regulator of the integrated stress response and cytosolic </pubmed_abstract><journal>JCI insight</journal><pubmed_title>ROCK1 promotes B cell differentiation and proteostasis under stress through the heme-regulated proteins, BACH2 and HRI.</pubmed_title><pmcid>PMC11949073</pmcid><funding_grant_id>P30 CA008748</funding_grant_id><funding_grant_id>R01 DK129946</funding_grant_id><funding_grant_id>R01AR078766,R01AI58579,R01DK129946,T32 AR071302,S10OD019986</funding_grant_id><funding_grant_id>T32 AR071302</funding_grant_id><funding_grant_id>R01 AR078766</funding_grant_id><funding_grant_id>S10 OD019986</funding_grant_id><pubmed_authors>Ricker E</pubmed_authors><pubmed_authors>Gupta S</pubmed_authors><pubmed_authors>Rivera-Correa J</pubmed_authors><pubmed_authors>Jenkins D</pubmed_authors><pubmed_authors>Pannellini T</pubmed_authors><pubmed_authors>Giannopoulou E</pubmed_authors><pubmed_authors>Flores-Castro D</pubmed_authors><pubmed_authors>Kim YB</pubmed_authors><pubmed_authors>Li Z</pubmed_authors><pubmed_authors>Phalke SP</pubmed_authors><pubmed_authors>Pernis AB</pubmed_authors><pubmed_authors>Zamponi N</pubmed_authors><pubmed_authors>Chinenov Y</pubmed_authors><pubmed_authors>Cerchietti L</pubmed_authors><pubmed_authors>Miele MM</pubmed_authors><pubmed_authors>Vulcano S</pubmed_authors></additional><is_claimable>false</is_claimable><name>ROCK1 promotes B cell differentiation and proteostasis under stress through the heme-regulated proteins, BACH2 and HRI.</name><description>The mechanisms utilized by differentiating B cells to withstand highly damaging conditions generated during severe infections, like the massive hemolysis that accompanies malaria, are poorly understood. Here, we demonstrate that ROCK1 regulates B cell differentiation in hostile environments replete with pathogen-associated molecular patterns (PAMPs) and high levels of heme by controlling 2 key heme-regulated molecules, BACH2 and heme-regulated eIF2α kinase (HRI). ROCK1 phosphorylates BACH2 and protects it from heme-driven degradation. As B cells differentiate, furthermore, ROCK1 restrains their pro-inflammatory potential and helps them handle the heightened stress imparted by the presence of PAMPs and heme by controlling HRI, a key regulator of the integrated stress response and cytosolic </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Feb</publication><modification>2026-06-02T07:21:02.043Z</modification><creation>2025-06-28T03:05:27.13Z</creation></dates><accession>S-EPMC11949073</accession><cross_references><pubmed>39903532</pubmed><doi>10.1172/jci.insight.180507</doi></cross_references></HashMap>